Pathophysiology of Coagulopathy Induced by Traumatic Brain Injury Is Identical to That of Disseminated Intravascular Coagulation With Hyperfibrinolysis

Background: Traumatic brain injury (TBI)-associated coagulopathy is a widely recognized risk factor for secondary brain damage and contributes to poor clinical outcomes. Various theories, including disseminated intravascular coagulation (DIC), have been proposed regarding its pathomechanisms; no consensus has been reached thus far. This study aimed to elucidate the pathophysiology of TBI-induced coagulopathy by comparing coagulofibrinolytic changes in isolated TBI (iTBI) to those in non-TBI, to determine the associated factors, and identify the clinical significance of DIC diagnosis in patients with iTBI.

Methods: This secondary multicenter, prospective study assessed patients with severe trauma. iTBI was defined as Abbreviated Injury Scale (AIS) scores ≥4 in the head and neck, and ≤2 in other body parts. Non-TBI was defined as AIS scores ≥4 in single body parts other than the head and neck, and the absence of AIS scores ≥3 in any other trauma-affected parts. Specific biomarkers for thrombin and plasmin generation, anticoagulation, and fibrinolysis inhibition were measured at the presentation to the emergency department (0 h) and 3 h after arrival.

Results: We analyzed 34 iTBI and 40 non-TBI patients. Baseline characteristics, transfusion requirements and in-hospital mortality did not significantly differ between groups. The changes in coagulation/fibrinolysis-related biomarkers were similar. Lactate levels in the iTBI group positively correlated with DIC scores (rho = −0.441, p = 0.017), but not with blood pressure (rho = −0.098, p = 0.614). Multiple logistic regression analyses revealed that the injury severity score was an independent predictor of DIC development in patients with iTBI (odds ratio = 1.237, p = 0.018). Patients with iTBI were further subdivided into two groups: DIC (n = 15) and non-DIC (n = 19) groups. Marked thrombin and plasmin generation were observed in all patients with iTBI, especially those with DIC. Patients with iTBI and DIC had higher requirements for massive transfusion and emergency surgery, and higher in-hospital mortality than those without DIC. Furthermore, DIC development significantly correlated with poor hospital survival; DIC scores at 0 h were predictive of in-hospital mortality.

Conclusions: Coagulofibrinolytic changes in iTBI and non-TBI patients were identical, and consistent with the pathophysiology of DIC. DIC diagnosis in the early phase of TBI is key in predicting the outcomes of severe TBI.

Introduction

Traumatic brain injury (TBI) is one of the leading causes of death and disability, with more than 10 million people hospitalized for TBI every year (1). Although primary damage to the brain is inevitable, secondary injuries are potentially avoidable and can affect the therapeutic interventions and outcomes of patients with TBI. TBI-associated coagulopathy is widely recognized as a risk factor for secondary brain damage and contributes to poor clinical outcomes. Two meta-analyses reported that the overall prevalence of TBI-associated coagulopathy was 32.7–35.2%, and a strong association was confirmed between the incidence of coagulopathy and poor outcomes (2, 3). TBI-associated coagulopathy contributes to poor outcomes in both hypocoagulability, leading to the expansion of intracranial hemorrhage, and hypercoagulability, leading to secondary cerebral ischemia due to intravascular thrombosis in the injured brain (4–8). Therefore, elucidation of the pathophysiology of TBI-induced coagulopathy may contribute to improving the outcomes of TBI patients, but no consensus has been reached thus far.

Disseminated intravascular coagulation (DIC) is acknowledged as the primary pathophysiological mechanism of trauma-induced coagulopathy (TIC), which is caused by multiple factors, such as anemia, hemodilution, hypothermia, acidosis, hemorrhagic shock, and serious trauma itself (9). Coagulopathy that occurs in patients with TBI is consistent with the definition of DIC proposed by the International Society on Thrombosis and Haemostasis: the activation of coagulation with the loss of localization and damage to the microvasculature (10, 11). Previous studies have clearly demonstrated consumption coagulopathy and disseminated microvascular thrombosis formation in the brain and other organs, which is the pathophysiology of DIC itself (12, 13).

A recent consensus statement from the International Society on Thrombosis and Haemostasis described that TIC is driven by two distinct and synergic insults: hypovolemic shock due to blood loss and extensive tissue disruption (14). However, it is unclear whether this concept can be applied to patients with TBI, since these patients do not suffer substantial blood loss, indicating that they are less likely to develop hemorrhagic shock.

Therefore, this study aimed to elucidate the pathophysiology of TBI-induced coagulopathy by comparing the coagulofibrinolytic changes in isolated TBI (iTBI) with those in non-TBI trauma, and to determine the associated factors, particularly shock-related factors such as blood pressure and serum lactate levels. To gain a deeper insight into the pathomechanisms of TBI-induced coagulopathy, coagulofibrinolytic changes were compared between iTBI patients with and without DIC, and the clinical significance of DIC diagnosis in patients with iTBI was evaluated.

Materials and Methods

Study Design, Setting, and Ethical Approval

This descriptive study was performed as a secondary analysis of a multicenter prospective study conducted by the Japanese Association for Acute Medicine (JAAM) Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis, and Trauma (FORECAST) study group (15). The JAAM FORECAST TRAUMA study recruited participants between April 1, 2016 and January 31, 2018, from 39 emergency departments (EDs) and intensive-care units (ICUs) in tertiary hospitals and was registered at the University Hospital Medical Information Network Clinical Trial Registry (UMIN-CTR ID: UMIN000019588). This study was approved under the condition that written informed consent was obtained from the patient or next of kin by the JAAM and the Ethics Committee of each hospital (JAAM, 2014-01; Hokkaido University Graduate School of Medicine, Head Institute of the FORECAST group, 014-0307) and was performed in accordance with the Declaration of Helsinki.

Participants

The JAAM FORECAST TRAUMA study enrolled adult trauma patients with severe trauma injury (aged ≥16 years old) with an Injury Severity Score (ISS) of ≥16 who were directly transported from the scene by emergency medical services. Patients with a history of cardiac arrest and resuscitation, who were receiving anticoagulants, who had hemorrhagic diathesis or coagulopathy due to any cause, or who had been transferred from other hospitals were excluded before registration. The size of the study population was dependent on the study period. All patients were followed up until discharge. Twenty-seven healthy volunteers who were not age- or sex-matched were enrolled to obtain the control values of the measured markers.

Definition and Diagnosis

Injury severity was assessed using the ISS. A DIC diagnosis was made based on the JAAM DIC diagnostic criteria (16) (Supplementary Table 1). The DIC scores were calculated at 0, 3, and 24 h, and the DIC group was defined as patients who met the DIC criteria at least once during the study period. In the present study, the prothrombin time international normalized ratio (PT-INR) was used as a substitute for the prothrombin time ratio for the diagnosis of DIC. Transfusion of packed red blood cells of more than the estimated circulating blood volume (7.5% of body weight) within 24 h after presentation to the ED met the definition of massive transfusion. Shock was defined as a systemic inflammatory response syndrome criteria were used to assess systemic inflammation (17). A systolic blood pressure of <90 mmHg at the scene or at the ED and lactate levels >2 mmol/L at the ED. The Charlson comorbidity index was used to assess comorbidities (18).

iTBI was defined as an Abbreviated Injury Scale (AIS) score of ≥4 in the head and neck and ≤2 in other body parts. To match the injury severity of iTBI, non-TBI was defined as an AIS score of ≥4 in one body part other than the head and neck and the absence of AIS score of ≥3 in any part affected by trauma.

Data Collection and Measurements

Immediately after arrival at the ED (0 h) and 3 h after admission (3 h), 15 mL of blood was collected in citrate containing tubes at each sampling point. The samples were immediately centrifuged at 4°C in the laboratories of each hospital, and the obtained plasma was stored at −80°C. All plasma samples were measured at the center laboratory of the LSI Medience Corporation (Tokyo, Japan). We measured the following molecular markers: (1) soluble fibrin (marker of direct thrombin generation) (LA, IATRO SFII; LSI Medience), (2) antithrombin (marker of anti-thrombin) (chromogenic assay, HemosIL Antithrombin LQ; Instrumental Laboratory), (3) protein C (marker of anticoagulation) (LPIA, LPIA-ACE PCII; LSI Medience), (4) plasmin antiplasmin complex (marker of plasmin generation) (LPIA, LPIA-ACE PPI II; LSI Medience), (5) plasminogen activator inhibitor-1 (PAI-1) (marker of inhibition of fibrinolysis) (LA, LPIA-tPAI test; LSI Medience), (6) D-dimer (marker of fibrinolysis) (LPIA, LPIA GENESIS D-dimer; LSI Medience), and (7) circulating activated protein C (APC) (marker of inhibition of thrombin) (EIA, EIA Kit For Activated Protein C Cloud-Clone Corp.). In addition to routine laboratory tests and blood gas analysis, measurements of platelet counts, PT-INR, activated partial thromboplastin time (APTT), fibrinogen, fibrin/fibrinogen degradation products (FDPs), and the FDP/D-dimer ratio, a surrogate marker of fibrin(ogen)olysis, were measured at 0, 3, and 24 h after arrival at the ED.

Statistical Analyses

Measurements are expressed as the median with the 25th−75th interquartile range or as numbers (percentages). Missing values were used without manipulation. Differences in demographics and measured parameters between the two groups were compared using the Mann–Whitney U-test for continuous variables and using either the chi-square test or Fisher's exact test for nominal variables when required. Platelet counts and global markers of coagulation and fibrinolysis were also evaluated using the Mann–Whitney U-test. Correlations were evaluated using Spearman's rank test when required. Survival probability curves with and without a DIC diagnosis in iTBI were constructed using the Kaplan–Meier method. The receiver operating characteristic (ROC) curve was constructed, and the area under the ROC curve (AUC) was used to assess the ability of DIC scores to predict in-hospital mortality. Differences were considered statistically significant at a two-tailed p < 0.05. SPSS software (version 26; IBM Japan, Tokyo, Japan) was used for all statistical analyses and calculations.

Results

Baseline Characteristics, Transfusion, and In-Hospital Mortality

In total, 295 consecutive patients were registered during the study period in the FORECAST TRAUMA cohort. Ultimately, 276 patients who met the eligibility criteria were divided into the iTBI (n = 34) and non-TBI (n = 40) groups (Supplementary Figure 1).

There were no significant differences in age, sex, comorbidities, or ISS between the groups. In addition, the DIC scores and prevalence at 0 and 3 h did not significantly differ between the groups (Table 1). The requirement for massive transfusion, transfusion volumes, and in-hospital mortality did not significantly differ between the two groups (Table 2).

TABLE 1

Table 1. Demographics and parameters at the scene and admission to the emergency department in patients with isolated traumatic brain injury and non-traumatic brain injury.

TABLE 2

Table 2. Requirement for transfusion and emergency surgery, and in-hospital mortality.

Comparison of Coagulofibrinolytic Changes Between the iTBI and Non-TBI Groups

Serial changes in the molecular markers of coagulation are shown in Figure 1. The levels of anticoagulation factors such as antithrombin and protein C were lower, while the levels of soluble fibrin and APC were significantly higher in the iTBI and non-TBI groups than in the healthy control group. These coagulation markers showed similar changes in patients with and without TBI. As shown in Figure 2, increased levels of plasmin-antiplasmin complex, D-dimer, and PAI-1 were observed in iTBI and non-TBI patients than in healthy controls. The levels of antiplasmin significantly decreased in the iTBI and non-TBI groups compared to those in the control group. These fibrinolysis-related molecular markers also underwent similar changes in the iTBI and non-TBI groups. In addition, serial changes in platelet counts and global markers of coagulation and fibrinolysis were similar between the groups (Supplementary Table 2).

FIGURE 1

Figure 1. Serial changes in the coagulation-related molecular markers. Healthy controls (white box), non-traumatic brain injury (TBI) (hatched boxes), and isolated TBI (iTBI) (gray boxes) at presentation to the emergency department (0 h) and 3 h after hospital arrival (3 h). The horizontal bars in the box indicate the median (middle) and interquartile ranges (upper 25% and lower 75%). Black boxes are mean values. +p < 0.05 vs. healthy controls; ++p < 0.01 vs. healthy controls; + + +p < 0.001 vs. healthy controls; + + ++p < 0.0001 vs. healthy controls. None of the markers significantly differed between the iTBI and non-TBI groups.

FIGURE 2

Figure 2. Serial changes in the fibrinolysis-related molecular markers. Healthy controls (white box), non-traumatic brain injury (TBI) (hatched boxes), and isolated TBI (iTBI) (gray boxes) at presentation to the emergency department (0 h) and 3 h after hospital arrival (3 h). Horizontal bars in the box indicate the median (middle) and interquartile ranges (upper 25% and lower 75%). Black boxes are mean values. +p < 0.05 vs. healthy controls, + + +p < 0.001 vs. healthy controls, + + ++p < 0.0001 vs. healthy controls. None of the markers significantly differed between the iTBI and non-TBI groups.

Factors Associated With Lactate Levels

Non-TBI patients exhibited lower systolic blood pressure at the scene and at the ED with a higher incidence of shock defined as a systolic blood pressure of <90 mmHg at the ED than the iTBI group. However, the incidence of shock defined by lactate levels of >2 mmol/L was identical between the two groups (Table 1). There was a negative correlation between systolic blood pressure and lactate levels in the non-TBI group (Spearman's rho = −0.403, p = 0.013; Figure 3A), while no significant correlation was observed between these variables in the iTBI group (Spearman's rho = 0.098, p = 0.614; Figure 3B). By contrast, no correlation was observed between lactate levels and the DIC score at 0 h in the non-TBI group (Spearman's rho = 0.085, p = 0.618; Figure 3C), but a positive correlation was observed between these values in the iTBI group (Spearman's rho = 0.441, p = 0.017; Figure 3D).

FIGURE 3

Figure 3. Spearman's rank correlation coefficients between the lactate levels and systolic blood pressure (SBP) at scene and the disseminated intravascular coagulation (DIC) score at arrival to the emergency department. TBI, traumatic brain injury; iTBI, isolated traumatic brain injury.

Factors Associated With the Development of DIC in the iTBI Group

Logistic regression analysis was performed to evaluate the factors associated with the development of DIC. Multiple logistic regression analysis indicated that ISS was an independent predictor of DIC development in patients with iTBI (odds ratio=1.237, p=0.018; Table 3).

TABLE 3

Table 3. Results of logistic regression analyses of variables predicting the development of disseminated intravascular coagulation in patients with isolated traumatic brain injury.

Baseline Characteristics, Transfusion, and In-Hospital Mortality in iTBI Patients With and Without DIC

Next, we focused on iTBI patients and divided them into the DIC group (n = 15) and the non-DIC group (n = 19). The baseline characteristics of the patients are presented in Table 4. The median ISSs in the DIC and non-DIC groups were 25 and 17, respectively. DIC patients had a higher AIS score in the head and worse Glasgow Coma Scale scores than non-DIC patients. The physiological parameter values at the scene and ED did not differ between the groups. Only few patients had blood pressure-defined shock in both groups, whereas >50% of the patients had lactate-defined shock (DIC, 83.3%; non-DIC, 58.8%). The median lactate levels in the DIC and non-DIC groups were 4.3 and 2.0 mmol/L, respectively. The requirements for massive transfusion and emergency surgery for TBI were significantly higher, and in-hospital mortality was higher in the DIC group than in the non-DIC group (Table 5). The survival probability was significantly lower among iTBI patients diagnosed with DIC immediately after presentation to the ED than among patients without DIC (log rank p=0.043; Figure 4A). ROC curves indicated that the DIC scores immediately after arrival to the ED were a good predictor of in-hospital mortality in patients with iTBI (AUC 0.866, p=0.019; Figure 4B).

TABLE 4

Table 4. Demographics and parameters at the scene and admission to the emergency department in isolated traumatic brain injury patients with and without disseminated intravascular coagulation.

TABLE 5

Table 5. Requirement for transfusion and emergency surgery, and in-hospital mortality in isolated traumatic brain injury patients with and without disseminated intravascular coagulation.

FIGURE 4

Figure 4. (A) Kaplan-Meier survival provability curves for mortality during hospitalization. Numbers at risk represent the number of patients with isolated traumatic brain injury (iTBI) with or without disseminated intravascular coagulation (DIC) at risk of death on the indicated days. (B) Receiver operating characteristics (ROC) curves of the DIC score immediately after arrival at emergency department. AUC, area under the ROC curve; SE, standard error.

Comparison of Coagulofibrinolytic Changes Between iTBI Patients With and Without DIC

Higher levels of soluble fibrin and lower levels of antithrombin were confirmed in iTBI patients with DIC than in those without DIC (Figure 5). As shown in Figure 6, there were increased plasmin generation and fibrinolysis and lower levels of antiplasmin at 0 and 3 h in the iTBI with DIC group than in the iTBI without DIC group. The PAI-1 levels in iTBI patients with DIC at 3 h after hospital arrival tended to be higher than those in patients without DIC (p = 0.091). Higher levels of FDP at 0 h and lower platelet counts were observed in iTBI patients with DIC than in those without DIC (Supplementary Table 3).

FIGURE 5

Figure 5. Serial changes in the coagulation-related molecular markers in patients with isolated traumatic brain injury. Healthy controls (white box), non-disseminated intravascular coagulation (DIC) (light gray boxes), and DIC (dark gray boxes) at presentation to the emergency department (0 h) and 3 h after hospital arrival (3 h). Horizontal bars in the box indicate the median (middle) and interquartile ranges (upper 25% and lower 75%). Black boxes represent the mean values. +p < 0.05 vs. healthy controls, ++p < 0.01 vs. healthy controls, + + +p < 0.001 vs. healthy controls, + + ++p < 0.0001 vs. healthy controls, ^*p < 0.05 vs. non-DIC, ^**p < 0.01 vs. non-DIC.

FIGURE 6

Figure 6. Serial changes in the fibrinolysis-related molecular markers in patients with isolated traumatic brain injury. Healthy controls (white box), non-disseminated intravascular coagulation (DIC) (light gray boxes) and DIC (dark gray boxes) at presentation to the emergency department (0 h) and 3 h after hospital arrival (3 h). Horizontal bars in the box indicate the median (middle) and interquartile ranges (upper 25% and lower 75%). Black boxes represent the mean values. +p < 0.005 vs. healthy controls, ++p < 0.001 vs. healthy controls, + + +p < 0.001 vs. healthy controls, + + ++p < 0.0001 vs. healthy controls, ^*p < 0.05 vs. non-DIC, ^***p < 0.001 vs. non-DIC.

Discussion

This study aimed to elucidate the pathophysiology of TBI-induced coagulopathy by comparing the coagulofibrinolytic changes in iTBI patient with those in non-TBI trauma patients, to determine the associated factors, and to identify the clinical significance of DIC diagnosis in patients with iTBI. In the present study, similar requirements for massive transfusion and in-hospital mortality were observed between iTBI and non-TBI patients with a similar severity of trauma. The changes in the levels of coagulofibrinolytic biomarkers were also identical between the groups. The lactate levels in the iTBI group were positively correlated with DIC scores but not with blood pressure. Moreover, the ISS was an independent predictor of DIC development in patients with iTBI. iTBI patients with DIC showed a significantly higher requirement for emergency surgery for TBI, and a higher incidence of massive transfusion than did those without DIC. DIC development was significantly associated with poor hospital survival, and DIC scores at 0 h were predictive of in-hospital mortality. In patients with iTBI with DIC, marked thrombin and plasmin generation was confirmed.

Although numerous mechanisms that are potentially associated with coagulopathy after TBI have been suggested, we previously demonstrated that the main pathomechanism of TIC, with or without TBI, is DIC (19–21). DIC is characterized by increased thrombin generation and subsequent consumption coagulopathy due to damage-associated molecular patterns derived from injured cells and tissues (22). That is, DIC is caused by trauma itself (23). However, another theory advocates that TBI alone does not cause early coagulopathy (24) and that coagulopathy occurs only in patients with shock-induced profound acidosis and high lactate concentrations (25–27). The results of the present study indicated no correlation between lactate levels and systolic blood pressure (Figure 3B) in iTBI patients, but the positive correlation between lactate levels and DIC score (Figure 3D) in those patients implies that the increase in lactate levels in TBI patients is caused by DIC-mediated secondary tissue hypoperfusion rather than by hypotension due to hemorrhagic shock. The results demonstrated that ISS was an independent predictor of pathological coagulofibrinolytic changes, namely DIC, in iTBI patients (Table 2), which also supports the concept that TIC is caused by trauma itself, with or without shock (23). The current results revealed similar coagulofibrinolytic changes, characterized by DIC with hyperfibrinolysis, between iTBI and non-TBI (Figures 1, 2), which was in line with the findings of a previous study (28).

iTBI patients with DIC had a higher requirement for massive transfusion and emergency surgery and had a higher in-hospital mortality than did those without DIC (Table 5). In addition, the DIC score in the iTBI group immediately after arrival to the hospital was predictive of in-hospital mortality (Figure 4B). Similar results have been reported not only in the setting of iTBI (2, 3), but also in other trauma settings (29). These results suggest the importance of DIC diagnosis in severely injured patients with or without TBI.

The present study revealed marked thrombin generation with lower levels of antithrombin in iTBI patients, particularly those with DIC (Figure 5). Previous studies confirmed such thrombin generation after iTBI, as evaluated by the high levels of the thrombin–antithrombin complex, prothrombin fragment 1 + 2, fibrinopeptide A, and fibrin monomers (28, 30, 31). High levels of soluble tissue factors have also been found (30, 32). Injury to the blood–brain barrier, caused by direct cerebral vascular disruption, potentially releases brain tissue factors into systemic circulation (5, 33). Tissue factors exposed to blood bind extensively to factor VIIa, followed by the initiation of the extrinsic coagulation pathway and subsequent consumption coagulopathy (23). Massive thrombin generation due to the activation of coagulation may lead to the consumption of anticoagulant factors, such as antithrombin and protein C, followed by further activation of coagulation. These changes contribute to hypercoagulability inside the vessels, leading to intravascular microthrombosis in the brain and other organs, and hypocoagulability outside the vessels due to consumptive coagulopathy, leading to the progression of intracranial hemorrhage (34).

This study demonstrated marked plasmin generation with lower levels of antiplasmin in iTBI and these changes were prominent in iTBI patients with DIC (Figure 6). Hyperfibrinolysis after trauma is caused by the release of tissue-type plasminogen activator (t–PA) from the endothelial Weibel-Palade bodies due to traumatic shock-induced tissue hypoperfusion (22). However, patients with iTBI with high lactate levels had no low blood pressure (Figure 3B), and similar results were reported previously (35). These results indicate that increases in lactate levels are not caused by low blood pressure-related hypoperfusion, but by DIC-induced tissue-hypoperfusion. That is, high lactate levels in iTBI with coagulopathy are a result rather than a cause of TIC. Instead of traumatic shock-induced tissue hypoperfusion, the direct release of t-PA from injured brain tissue has been acknowledged as another explanation of hyperfibrinolysis in patients with iTBI (11). A previous study demonstrated that endogenous t-PA increases the lysis of plasma clots and contributes to intracerebral hemorrhage after TBI (36).

Study Limitations

Several limitations of our study need to be considered. First, although the present dataset was prospectively collected, causal relationships could not be defined because of the retrospective study design and missing values. Second, this study included a small number of patients. Third, we did not distinguish types of TBI (e.g., acute subdural hematoma, traumatic subarachnoid hemorrhage, and contusion), which may affect the pathology and severity of TBI-induced coagulopathy. Fourth, although more patients received tranexamic acid in the iTBI group than in the non-TBI group, the effects of tranexamic acid on the levels of coagulation and fibrinolysis-related markers were not determined. Fifth, bias may exist in trauma types in the non-TBI group, as suggested by the finding that many patients in this group had severe thoracic injury. Finally, this was a single nationwide study conducted in a developed country, which may have limited the global generalization of the results.

Conclusions

The present study demonstrated similar coagulofibrinolytic changes between iTBI and non-TBI patients, which are consistent with DIC. Marked generation of thrombin and plasmin was confirmed in iTBI patients, and these changes were more prominent in iTBI patients with DIC. The development of DIC in patients with iTBI was associated with a poor survival outcome, and DIC scores immediately after hospital arrival could predict in-hospital death. Therefore, the diagnosis of DIC in the early phase of trauma is important for predicting the outcome of severely injured patients, including those with iTBI.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

This study was approved under the condition that written informed consent was obtained from the patient or next of kin by the JAAM and the Ethics Committee of each hospital (JAAM, 2014-01; Hokkaido University Graduate School of Medicine, Head institute of the FORECAST group, 014-0307). Written informed consent to participate in this study was provided by the participants' legal guardian/next of kin.

Author Contributions

TW analyzed the study results, interpreted the data, and drafted the manuscript. AS checked the statistical methods and results. AS, SG, KY, SFujis, DS, SK, HO, TA, TM, JS, JK, NT, RT, KT, SS, YSh, TN, KO, YSa, AH, SFujim, YU, and YO planned the study, decided the methods, developed a web-based registration system, discussed the results, and critically revised the manuscript. All authors have read and approved the final version of the manuscript.

Funding

This study was supported by the Japanese Association for Acute Medicine (JAAM, 2014-01). This work was also supported in part by JSPS KAKENHI (Grant-in-Aid (C) 2020, 20K09260).

Conflict of Interest

AS reported receiving personal fees from CSL Behring outside of the submitted work. SG reported receiving personal fees from Asahi Kasei Pharma America Inc. and Asahi Kasei Pharma Japan Inc. outside of the submitted work.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We would like to thank Editage (www.editage.com) for English language editing. We wish to express our gratitude to all JAAM FORECAST Trauma investigators: Osaka City University Hospital (Yasumitsu Mizobata), National Hospital Organization Sendai Medical Center (Yasuo Yamada), Saitama Medical University Saitama Medical Center (Satoru Sugiyama), Fukui Prefectural Hospital (Hiroshi Ishida), Sapporo Medical University (Eichi Narimatsu), Fukuyama City Hospital (Koji Miyasho), Hiratsuka City Hospital (Toshio Kanai), Saiseikai Utsunomiya Hospital (Satoru Miyatake), Japanese Red Cross Society Kyoto Daini Hospital (Ryouji Iiduka), Shinsyu University School of Medicine (Hiroshi Imamura), Rinku General Medical Center (Yasuaki Mizushima), Subaru Health Insurance Society Ota Memorial Hospital (Yoshitake Sato), Saitama Medical University International Medical Center (Manabu Nemoto), Aomori Prefectural Central Hospital (Hiroyuki Hanada), National Hospital Organization Hokkaido Medical Center (Yasuo Shichinohe), Saga-ken Medical Center Koseikan (Kenji Hirahara), Hachinohe City Hospital (Akihide Kon), Juntendo University Nerima Hospital (Manabu Sugita), Kawaguchi Municipal Medical Center (Yasutaka Naoe), Kakogawa West City Hospital (Manabu Kirita), Osaka National Hospital (Daikai Sadamitsu), and Kouseiren Takaoka Hospital (Masahiro Yoshida). Additionally, the JAAM FORECST Study Group thanks Shuta Fukuda for his special assistance in completing the study.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2021.767637/full#supplementary-material

References

1. Iaccarino C, Carretta A, Nicolosi F, Morselli C. Epidemiology of severe traumatic brain injury. J Neurosurg Sci. (2018) 62:535–41. doi: 10.23736/S0390-5616.18.04532-0

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI. Coagulation disorders after traumatic brain injury. Acta Neurochir. (2008) 150:165–75; discussion 75. doi: 10.1007/s00701-007-1475-8

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Epstein DS, Mitra B, O'Reilly G, Rosenfeld JV, Cameron PA. Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: a systematic review and meta-analysis. Injury. (2014) 45:819–24. doi: 10.1016/j.injury.2014.01.011

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Zou Z, Li L, Schäfer N, Huang Q, Maegele M, Gu Z. Endothelial glycocalyx in traumatic brain injury associated coagulopathy: potential mechanisms and impact. J Neuroinflammation. (2021) 18:134. doi: 10.1186/s12974-021-02192-1

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Maegele M, Schöchl H, Menovsky T, Maréchal H, Marklund N, Buki A, et al. Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management. Lancet Neurol. (2017) 16:630–47. doi: 10.1016/S1474-4422(17)30197-7

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Stein SC, Young GS, Talucci RC, Greenbaum BH, Ross SE. Delayed brain injury after head trauma: significance of coagulopathy. Neurosurgery. (1992) 30:160–5. doi: 10.1097/00006123-199202000-00002

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Stein SC, Chen XH, Sinson GP, Smith DH. Intravascular coagulation: a major secondary insult in nonfatal traumatic brain injury. J Neurosurg. (2002) 97:1373–7. doi: 10.3171/jns.2002.97.6.1373

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Stein SC, Graham DI, Chen XH, Smith DH. Association between intravascular microthrombosis and cerebral ischemia in traumatic brain injury. Neurosurgery. (2004) 54:687–91; discussion 91. doi: 10.1227/01.NEU.0000108641.98845.88

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Gando S, Sawamura A, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg. (2011) 254:10–9. doi: 10.1097/SLA.0b013e31821221b1

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. (2001) 86:1327–30. doi: 10.1055/s-0037-1616068

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Gando S. Hemostasis and thrombosis in trauma patients. Semin Thromb Hemost. (2015) 41:26–34. doi: 10.1055/s-0034-1398378

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Kaufman HH, Hui KS, Mattson JC, Borit A, Childs TL, Hoots WK, et al. Clinicopathological correlations of disseminated intravascular coagulation in patients with head injury. Neurosurgery. (1984) 15:34–42. doi: 10.1097/00006123-198407000-00007

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Stein SC, Smith DH. Coagulopathy in traumatic brain injury. Neurocrit Care. (2004) 1:479–88. doi: 10.1385/NCC:1:4:479

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Moore HB, Gando S, Iba T, Kim PY, Yeh CH, Brohi K, et al. Defining trauma-induced coagulopathy with respect to future implications for patient management: communication from the SSC of the ISTH. J Thromb Haemost. (2020) 18:740–7. doi: 10.1111/jth.14690

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Gando S, Shiraishi A, Wada T, Yamakawa K, Fujishima S, Saitoh D, et al. A multicenter prospective validation study on disseminated intravascular coagulation in trauma-induced coagulopathy. J Thromb Haemost. (2020) 18:2232–44. doi: 10.1111/jth.14931

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Gando S, Saitoh D, Ogura H, Mayumi T, Koseki K, Ikeda T, et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med. (2008) 36:145–50. doi: 10.1097/01.CCM.0000295317.97245.2D

PubMed Abstract | CrossRef Full Text | Google Scholar

17. American college of chest physicians/society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. (1992) 20:864–74. doi: 10.1097/00003246-199206000-00025

CrossRef Full Text

18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. (1987) 40:373–83. doi: 10.1016/0021-9681(87)90171-8

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Gando S, Nanzaki S, Kemmotsu O. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis. Ann Surg. (1999) 229:121–7. doi: 10.1097/00000658-199901000-00016

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Gando S. Disseminated intravascular coagulation in trauma patients. Semin Thromb Hemost. (2001) 27:585–92. doi: 10.1055/s-2001-18864

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Gando S. Acute coagulopathy of trauma shock and coagulopathy of trauma: a rebuttal. You are now going down the wrong path. J Trauma. (2009) 67:381–3. doi: 10.1097/TA.0b013e3181a84f63

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Gando S, Otomo Y. Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock. Crit Care. (2015) 19:72. doi: 10.1186/s13054-015-0735-x

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Gando S, Hayakawa M. Pathophysiology of trauma-induced coagulopathy and management of critical bleeding requiring massive transfusion. Semin Thromb Hemost. (2016) 42:155–65. doi: 10.1055/s-0035-1564831

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Cohen MJ, Brohi K, Ganter MT, Manley GT, Mackersie RC, Pittet JF. Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway. J Trauma. (2007) 63:1254–61; discussion 61–2. doi: 10.1097/TA.0b013e318156ee4c

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg. (2007) 245:812–8. doi: 10.1097/01.sla.0000256862.79374.31

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. (2008) 64:1211–7; discussion 7. doi: 10.1097/TA.0b013e318169cd3c

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. (2008) 65:748–54. doi: 10.1097/TA.0b013e3181877a9c

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Gando S, Nanzaki S, Kemmotsu O. Coagulofibrinolytic changes after isolated head injury are not different from those in trauma patients without head injury. J Trauma. (1999) 46:1070–6; discussion 6–7. doi: 10.1097/00005373-199906000-00018

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Wada T, Shiraishi A, Gando S, Yamakawa K, Fujishima S, Saitoh D, et al. Disseminated intravascular coagulation immediately after trauma predicts a poor prognosis in severely injured patients. Sci Rep. (2021) 11:11031. doi: 10.21203/rs.3.rs-199070/v1

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Di Battista AP, Rizoli SB, Lejnieks B, Min A, Shiu MY, Peng HT, et al. Sympathoadrenal activation is associated with acute traumatic coagulopathy and endotheliopathy in isolated brain injury. Shock. (2016) 46:96–103. doi: 10.1097/SHK.0000000000000642

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Esnault P, Mathais Q, D'Aranda E, Montcriol A, Cardinale M, Cungi PJ, et al. Ability of fibrin monomers to predict progressive hemorrhagic injury in patients with severe traumatic brain injury. Neurocrit Care. (2020) 33:182–95. doi: 10.1007/s12028-019-00882-6

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Rhind SG, Crnko NT, Baker AJ, Morrison LJ, Shek PN, Scarpelini S, et al. Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients. J Neuroinflammation. (2010) 7:5. doi: 10.1186/1742-2094-7-5

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Maegele M, Aversa J, Marsee MK, McCauley R, Chitta SH, Vyakaranam S, et al. Changes in coagulation following brain injury. Semin Thromb Hemost. (2020) 46:155–66. doi: 10.1055/s-0040-1702178

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Wada T, Yamakawa K. Trauma-induced coagulopathy: the past, present, and future: a comment. J Thromb Haemost. (2019) 17:1571–4. doi: 10.1111/jth.14571

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Wada T, Gando S, Maekaw K, Katabami K, Sageshima H, Hayakawa M, et al. Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury. Crit Care. (2017) 21:219. doi: 10.1186/s13054-017-1808-9

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Hijazi N, Abu Fanne R, Abramovitch R, Yarovoi S, Higazi M, Abdeen S, et al. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice. Blood. (2015) 125:2558–67. doi: 10.1182/blood-2014-08-588442

PubMed Abstract | CrossRef Full Text | Google Scholar